We are a drug development company specializing in real pediatric medicine by reformulating compounds currently approved for adults with substantial safety and efficacy and determining an accurate pediatric dosage. Currently, 70% of the drugs prescribed for children are not approved by the FDA. Children metabolize drugs more rapidly than adults; our goal is to eliminate the "dosing down" of adult drugs for children based on weight. Madeira Therapeutics is one of the few drug development companies with a dedicated focus on this niche market-formulations that are sized to fit.
View Top Employees from Madeira TherapeuticsWebsite | http://www.madeiratherapeutics.com/ |
Revenue | $5.1 million |
Employees | 1 (1 on RocketReach) |
Founded | 2007 |
Address | 4745 W. 136th Street Suite # 102, Leawood, Kansas 66224, US |
Phone | (913) 661-1962 |
Technologies |
JavaScript,
HTML,
Nginx
+2 more
(view full list)
|
Industry | Biotechnology, Business Services General, Business Services, Science and Engineering, Medical, Health Care, Medical Device |
Competitors | Beta Pharma, Inc., Perosphere Inc., SFJ Pharmaceuticals, Inc., Sciecure Pharma |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Madeira Therapeutics employee's phone or email?
The Madeira Therapeutics annual revenue was $5.1 million in 2024.
1 people are employed at Madeira Therapeutics.
Madeira Therapeutics is based in Leawood, Kansas.
The NAICS codes for Madeira Therapeutics are [3254, 325, 32].
The SIC codes for Madeira Therapeutics are [28, 283].